Stock A106190 HIGH TECH PHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials High Tech Pharm Co., Ltd.

Equities

A106190

KR7106190002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
10,560 KRW -.--% Intraday chart for High Tech Pharm Co., Ltd. +3.33% +13.18%
2023 High Tech Pharm Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 High Tech Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 123,345 80,103 130,788 97,116 77,268 99,208
Enterprise Value (EV) 1 126,616 80,583 140,231 100,455 85,811 110,342
P/E ratio 47.3 x -19 x -41.5 x -79.3 x 13.2 x 12.3 x
Yield - - - - - -
Capitalization / Revenue 1.86 x 1.27 x 1.76 x 1.33 x 0.75 x 1.29 x
EV / Revenue 1.91 x 1.28 x 1.88 x 1.37 x 0.83 x 1.44 x
EV / EBITDA 49.1 x 82.4 x 65.9 x 19.5 x 8.19 x 7.32 x
EV / FCF -24.7 x 42.8 x -23.6 x 15.8 x -14.4 x -20.2 x
FCF Yield -4.05% 2.34% -4.23% 6.33% -6.94% -4.96%
Price to Book 1.19 x 0.81 x 1.37 x 1.03 x 0.77 x 0.93 x
Nbr of stocks (in thousands) 10,633 10,633 10,633 10,633 10,633 10,633
Reference price 2 11,600 7,533 12,300 9,133 7,267 9,330
Announcement Date 3/1/19 2/29/20 3/1/21 3/1/22 3/1/23 2/29/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 66,388 63,068 74,462 73,287 102,947 76,772
EBITDA 1 2,581 978.1 2,128 5,139 10,472 15,075
EBIT 1 2,083 -4,525 -3,324 -412 4,927 10,089
Operating Margin 3.14% -7.17% -4.46% -0.56% 4.79% 13.14%
Earnings before Tax (EBT) 1 3,251 -3,905 -2,600 -867.9 4,028 9,864
Net income 1 2,608 -4,218 -3,152 -1,225 5,873 8,076
Net margin 3.93% -6.69% -4.23% -1.67% 5.7% 10.52%
EPS 2 245.3 -396.7 -296.4 -115.2 552.3 760.0
Free Cash Flow 1 -5,126 1,884 -5,939 6,360 -5,955 -5,473
FCF margin -7.72% 2.99% -7.98% 8.68% -5.78% -7.13%
FCF Conversion (EBITDA) - 192.6% - 123.76% - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/1/19 2/29/20 3/1/21 3/1/22 3/1/23 2/29/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 3,271 480 9,443 3,338 8,543 11,135
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.267 x 0.4906 x 4.437 x 0.6496 x 0.8158 x 0.7386 x
Free Cash Flow 1 -5,126 1,884 -5,939 6,360 -5,955 -5,473
ROE (net income / shareholders' equity) 2.54% -4.18% -3.25% -1.3% 6.06% 7.81%
ROA (Net income/ Total Assets) 1.03% -2.14% -1.6% -0.2% 2.41% 4.72%
Assets 1 252,583 197,406 197,386 598,340 243,286 171,163
Book Value Per Share 2 9,719 9,271 8,948 8,829 9,399 10,086
Cash Flow per Share 2 373.0 292.0 97.60 1,060 741.0 328.0
Capex 1 10,348 2,157 937 860 656 5,091
Capex / Sales 15.59% 3.42% 1.26% 1.17% 0.64% 6.63%
Announcement Date 3/1/19 2/29/20 3/1/21 3/1/22 3/1/23 2/29/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
HIGH TECH PHARM CO., LTD. Stock High Tech Pharm Co., Ltd.
+13.18% 81.13M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.27% 43.18B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+24.05% 23.23B
SANDOZ GROUP AG Stock Sandoz Group AG
+15.11% 14.6B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.36% 11.5B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-7.63% 6.79B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+10.21% 5.31B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-2.27% 4.81B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A106190 Stock
  4. Financials High Tech Pharm Co., Ltd.